Meet Our Board of Directors
Dr. Thomas “Rock” Mackie
Dr. Mackie currently serves as Director of Medical Devices at the Morgridge Institute for Research and as a professor in the departments of Medical Physics, Human Oncology, and Engineering Physics at the University of Wisconsin–Madison. He is the author of more than 130 peer-reviewed publications, 25 patents, and has supervised more than 25 PhD students. With his expertise in radiation therapy treatment planning and intensity-modulated radiotherapy, his group developed the PinnacleTMtreatment planning system, now marketed by Philips Medical. He is a co-founder and Chairman of the Board of TomoTherapy, Inc., a Madison-based company employing 650 people. Dr. Mackie received his B.S. in Physics from the University of Saskatchewan in 1980 and his doctorate in Physics from the University of Alberta in 1984.
Dr. Gregory Piefer
Dr. Piefer is the founder and CEO of SHINE Medical Technologies, and has 13 years of executive management experience at growth stage technology companies. Before SHINE, he served as the president of Phoenix Nuclear Labs, where he managed the development of high-output particle sources. He formerly served as the Chief Technical Officer to Gillware Inc., a leading data recovery and backup company. He holds a PhD in nuclear engineering, and BS degrees in physics and electrical and computer engineering from the University of Wisconsin–Madison. Greg has received numerous awards and honors including the prestigious UW-Madison Early Career award, is the primary inventor on multiple patents and author or co-author of numerous publications, and serves on the boards of several profit and non-profit entities. His passion is the growth of technology companies that take scientific advancement to commercialization, providing the opportunity to serve and better humanity.
Philip M. Halpern
Mr. Halpern is the managing partner of the law firm of Collier, Halpern, Newberg, Nolletti & Bock, LLP, with offices in New York City, White Plains and Stamford, Connecticut. Mr. Halpern is a magna cum laude graduate of Fordham University, where he majored in economics, and is a graduate of Pace University School of Law where he obtained his juris doctor. Mr. Halpern is a Fellow of the American Bar Foundation and member of the Office of Court Administration’s Advisory Committee on Civil Practice. Mr. Halpern has been a member of the Advisory Council for the Board of Judges for the Southern District of New York. Mr. Halpern is a member of the Association of the Bar of the City of New York, the Committee on Federal Judiciary for the New York State Bar Association, the American Bar Association, the New York County Lawyers Association, New York State Trial Lawyers Association, the Association of Trial Lawyers of America, and the Federal Bar Council. Mr. Halpern began his legal career in 1980 as a law clerk to a federal judge in the Southern District of New York.
Todd Asmuth joined SHINE as its President in September 2015 after spending 5 years as CEO of AquaMost, Inc. He has spent 20 years building early stage companies as an operator and investor. Immediately prior to AquaMost, he was the President of Surebond, a specialty chemical manufacturer with a line of environmentally friendly adhesives and sealants. He has a history of successfully taking companies from concept to commercialization to profitability using lean startup, customer-focused product development techniques. In addition, he sits on the board of directors of multiple early stage companies and non-profit organizations. Early in his career, Todd spent 4 years in management consulting with Booz Allen & Hamilton on strategy engagements with Fortune 500 companies. Todd earned an MBA with honors from the Kellogg School of Management at Northwestern University and a B.S. in Mechanical Engineering from Yale University. He is a member of the Society of Petroleum Engineers.
Gregory OD Smith
Gregory OD Smith joins the SHINE board with 39 years of leadership experience in the nuclear industry and a track record of creating effective partnerships. Gregory has served as the Chairman of Urenco UK and Urenco’s Chief Culture Officer. Prior to that, he served as Chairman of the Board and Chief Executive Officer for Louisiana Energy Services (LES), a uranium enrichment company wholly owned by Urenco. As CEO of LES, he oversaw the completion of construction and startup of the National Enrichment Facility in New Mexico. Before joining LES, Mr. Smith worked for Ontario Power Generation. During 2002‑2006, he served as the Senior Vice President for the 4-unit Darlington Nuclear station. From 1992-2002, he worked at Energy Northwest where he held several positions, including Operations Division Manager, Plant General Manager, Vice President Nuclear Operations, and Vice President Generation.
President of Baker Construction Enterprises. Prior to joining Baker in 2010, Mr. Wucherpfennig was a member of the Advisory Board for over ten years while serving as CEO of Phillips-Medisize, a global leader in outsource design, development, and technology-driven manufacturing providing drug delivery, medical device, and medical diagnostic products. Mr. Wucherpfennig, a Wisconsin native, lived in Minneapolis for numerous years. He served as the Executive Vice President and COO of Schwing America, Inc., a member of the Schwing Group, a worldwide designer, manufacturer and distributor of concrete production and handling equipment. His career began with Ernst and Young in Minnesota, where as a CPA he performed client audits. After his time in public accounting, he served as the Director of International Finance for Synder General Corporation, a designer and manufacturer of commercial and industrial air conditioning and handling equipment. Mr. Wucherpfennig has a degree in Finance/Accounting from the University of Wisconsin and holds an MBA from the University of Minnesota. He has served on numerous boards in the construction, manufacturing, and medical technology industries.
Mr. Gunnlaugsson was employed at Marshall and Ilsley Corporation, an S&P 500 banking company, for thirty years, serving most recently as CFO and EVP and as a Director. Currently, he is a principal in Lakeview Equity Partners, a private equity firm in Milwaukee, Wisconsin. Mr. Gunnlaugsson’s other activities include serving as a director for a variety of other firms including West Bend Mutual Insurance Company, Fiduciary Management Mutual Funds, UAS Labs, and Renaissance Learning, Inc. He has also served as Chairman of the Milwaukee Economic Development Corporation, Chairman of the Medical College of Wisconsin Cardiovascular Center Advisory Board, Chairman of the UW School of Business Puelicher Center for Banking, and Chairman of the UW School of Business Dean’s Advisory Board. He is a CPA and holds a BBA and MBA from the UW School of Business and is a recipient of their Distinguished Alumni Award.
Meet Our Advisers
Dr. Paul M. DeLuca
Dr. DeLuca received his B.S. in physics and math in 1966 and a doctorate in nuclear physics from the University of Notre Dame in 1971. That same year he joined the University of Wisconsin–Madison, and has since served as a professor in the departments of Medical Physics, Radiology, Human Oncology, Engineering Physics and Physics. He now serves as Provost and Vice Chancellor for Academic Affairs. Dr. DeLuca’s research interests have concentrated on fast neutron dosimetry including production of intense sources of fast neutrons, determination of elemental neutron kerma factors and application of microdosimetry to radiation dosimetry. He is currently vice chairman of the International Commission on Radiation Units and Measurements at Los Alamos.
Dr. Harrison Schmitt
Dr. Harrison Schmitt has a diverse professional background having served as a geologist, pilot, astronaut, businessman, writer and United States Senator. Selected for the Scientist-Astronaut Program in 1965. He served as a Mission Scientist in support of the Apollo 11 mission. After training as back-up Lunar Module pilot for Apollo 15, Dr. Schmitt flew in space as Lunar Module pilot for Apollo 17 – the last Apollo mission to the Moon. He was the only scientist and the last of twelve men to step onto the Moon. He served in the U.S. Senate, continues to work in science, aerospace and business, and chaired the NASA Advisory Council from 2005-2008. Schmitt serves as Adjunct Professor of Engineering at the University of Wisconsin–Madison. In addition to being active in considerations of space biomedical adaptation, he has worked in the biomedical field as Acting CEO for the Lovelace Medical Foundation and currently as a Director of PHDx Systems, a software developer and supplier for medical device outcomes. Schmitt is the author of “Return to the Moon” (Copernicus-Praxis 2006), a book advocating a private sector initiative to develop lunar helium-3 fusion power for use on Earth.
James L. Connaughton
Mr. Connaughton is Executive Vice President with C3 Energy, which offers big data energy analytics solutions to utilities and to oil and gas companies. Prior to joining C3 Energy, Mr. Connaughton served as Executive Vice President and Senior Policy Advisor of Exelon Corporation, and Executive Vice President, Corporate Affairs, Public and Environmental Policy for Constellation Energy. From 2001 to 2009, Mr. Connaughton was Chairman of the White House Council on Environmental Quality. In this capacity, he served on President Bush’s staff as senior environment, energy and natural resources advisor and as director of the White House Office of Environmental Policy. He holds a bachelor’s degree from Yale University and a J.D. from Northwestern University School of Law.
Mr. Klug is the Managing Director of Public Affairs at the national law firm of Foley & Lardner LLP. He chairs the firm’s Client Service Team. For eight years, Mr. Klug represented Madison, Wisconsin in the U.S. Congress, where he developed an expertise in health care, energy policy and financial services. He was appointed by President Bush for two terms to the Advisory Committee to the United States Trade Representative. Prior to his election to Congress, he was an Emmy award-winning reporter/anchor in Washington, D.C., Seattle and his native Wisconsin. A novelist, his freelance writing has appeared in a number of U.S. newspapers and magazines. Before he joined Foley, he founded a regional magazine and book publishing company which he sold in 2007. Mr. Klug holds an M.B.A. in finance from the University of Wisconsin, a Master’s in journalism from Northwestern and a B.A. from Lawrence University.
Mr. Manuele is a results-oriented, innovative executive with thirty five years of comprehensive US and International expertise in nuclear medicine and medical isotope production. A long-time veteran of Amersham Health and GE Healthcare, he has launched core products, expanded products internationally, led the design, construction and FDA-approval of two brand new U.S. manufacturing facilities, and held responsibility for several full-GMP radiopharmaceutical manufacturing sites across the US and Europe. Before his retirement in 2008, Mr. Manuele served as General Manager – Global Nuclear Medicine Supply Chain for GE Healthcare, and General Manager – Oncura, GE’s global I-125 brachytherapy seeds business. He has an impeccable track record of operational excellence, continuous profitability improvement, and implementation of industry-leading quality systems.
Mr. Coombs is a recognized leader in the nuclear medicine industry. Most recently, as President of Jubilant DraxImage, he led the company through a period of rapid organic growth, tripling revenue in four years. He built a strong team, advanced the development pipeline toward approval, and built the company’s strategy toward becoming the industry leader. Mr. Coombs has also spent nine years with Amersham/GE Healthcare, including five years in Japan as the Executive Vice President of Nihon Medi-Physics. He holds a degree in Mathematics and an MBA with distinction from Warwick Business School. In 2017, he was appointed as the new CEO of ImaginAb.
Donald J. Whelley
Mr. Whelley is the Managing Member of DJW Advisors, providing advisory services to institutional and high net worth clients. He has worked for over thirty years in energy and financial services providing valuation and advisory services and most recently supporting clients investing in other industry sectors including mining and biotech. After graduating with a B.S. in Accounting from Clarkson University, Mr. Whelley began his professional career working as an auditor for Arthur Andersen. His career has included accounting, finance and acquisition work for companies involved in oil and gas, agricultural biotech, broker dealer and syndication of real estate investments and energy consulting. In addition to his Director role at SHINE, Mr. Whelley also serves as a Director of Phoenix Nuclear Labs, a private manufacturer of commercial neutron generators, a Director of GeoResources Inc. a Houston, Texas based publicly traded exploration & production company, Board Observer of Dynamis Therapeutics, Inc., a private biotech company, Board Observer of Flugen, Inc., a private manufacturer of medical devices and vaccines, and Advisory Board member of Blue Ocean Consulting, Inc., an internet software and consulting firm.